Invasive breast carcinoma - IARC

1132. Hanselaar AG, Boss EA, Massuger
LF, Bernheim JL (1999). Cytologic examination
to detect clear cell adenocarcinoma of
the vagina or cervix. Gynecol Oncol 75:
338-344.
1133. Hanssen AM, Fryns JP (1995).
Cowden syndrome. J Med Genet 32: 117-
119.
1134. Harada Y, Katagiri T, Ito I, Akiyama F,
Sakamoto G, Kasumi F, Nakamura Y, Emi M
(1994). Genetic studies of 457 breast cancers.
Clinicopathologic parameters compared
with genetic alterations. Cancer 74:
2281-2286.
1135. Hardesty LA, Sumkin JH, Hakim C,
Johns C, Nath M (2001). The ability of helical
CT to preoperatively stage endometrial
carcinoma. Am J Roentgenol 176: 603-606.
1136. Hardesty LA, Sumkin JH, Nath ME,
Edwards RP, Price FV, Chang TS, Johns
CM, Kelley JL (2000). Use of preoperative
MR imaging in the management of
endometrial carcinoma: cost analysis.
Radiology 215: 45-49.
1137. Hardisson D, Simon RS, Burgos E
(2001). Primary osteosarcoma of the uterine
corpus: report of a case with immunohistochemical
and ultrastructural study.
Gynecol Oncol 82: 181-186.
1138. Harkin DP, Bean JM, Miklos D, Song
YH, Truong VB, Englert C, Christians FC,
Ellisen LW, Maheswaran S, Oliner JD,
Haber DA (1999). Induction of GADD45 and
JNK/SAPK-dependent apoptosis following
inducible expression of BRCA1. Cell 97:
575-586.
1139. Harlow BL, Weiss NS, Lofton S (1986).
The epidemiology of sarcomas of the
uterus. J Natl Cancer Inst 76: 399-402.
1140. Harnden P, Kennedy W, Andrew AC,
Southgate J (1999). Immunophenotype of
transitional metaplasia of the uterine
cervix. Int J Gynecol Pathol 18: 125-129.
1141. Haroske G, Giroud F, Reith A, Bocking
A (1998). 1997 ESACP consensus report on
diagnostic DNA image cytometry. Part I:
basic considerations and recommendations
for preparation, measurement and
interpretation. European Society for
Analytical Cellular Pathology. Anal Cell
Pathol 17: 189-200.
1142. Harris M, Howell A, Chrissohou M,
Swindell RI, Hudson M, Sellwood RA
(1984). A comparison of the metastatic pattern
of infiltrating lobular carcinoma and
infiltrating duct carcinoma of the breast.
Br J Cancer 50: 23-30.
1143. Harris M, Wells S, Vasudev KS (1978).
Primary signet ring cell carcinoma of the
breast. Histopathology 2: 171-176.
1144. Harris NL, Jaffe ES, Diebold J,
Flandrin G, Muller-Hermelink HK, Vardiman
J, Lister TA, Bloomfield CD (2000). The
World Health Organization classification of
hematological malignancies report of the
Clinical Advisory Committee Meeting,
Airlie House, Virginia, November 1997.
Mod Pathol 13: 193-207.
1145. Harris NL, Scully RE (1984). Malignant
lymphoma and granulocytic sarcoma of
the uterus and vagina. A clinicopathologic
analysis of 27 cases. Cancer 53: 2530-2545.
1146. Harrison M, Magee HM, O'Loughlin
J, Gorey TF, Dervan PA (1995).
Chromosome 1 aneusomy, identified by
interphase cytogenetics, in mammograph -
ically detected ductal carcinoma in situ of
the breast. J Pathol 175: 303-309.
1147. Hart WR (1977). Ovarian epithelial
tumors of borderline malignancy (carcinomas
of low malignant potential). H u m
Pathol 8: 541-549.
1148. Hart WR, Billman JK Jr. (1978). A
reassessment of uterine neoplasms originally
diagnosed as leiomyosarcomas.
Cancer 41: 1902-1910.
1149. Hart WR, Craig JR (1978).
Rhabdomyosarcomas of the uterus. Am J
Clin Pathol 70: 217-223.
1150. Hart WR, Norris HJ (1973). Borderline
and malignant mucinous tumors of the
ovary. Histologic criteria and clinical
behavior. Cancer 31: 1031-1045.
1151. Hartge P, Struewing JP, Wacholder
S, Brody LC, Tucker MA (1999). The prevalence
of common BRCA1 and BRCA2 mutations
among Ashkenazi Jews. Am J Hum
Genet 64: 963-970.
1152. Hartveit E (1990). Attenuated cells in
breast stroma: the missing lymphatic system
of the breast. Histopathology 16: 533-
543.
1153. Hasebe T, Mukai K, Tsuda H, Ochiai A
(2000). New prognostic histological parameter
of invasive ductal carcinoma of the
breast: clinicopathological significance of
fibrotic focus. Pathol Int 50: 263-272.
1154. Hashiguchi J, Ito M, Kishikawa M,
Sekine I, Kase Y (1994). Intravascular
leiomyomatosis with uterine lipoleiomyoma.
Gynecol Oncol 52: 94-98.
1155. Haskel S, Chen SS, Spiegel G (1989).
Vaginal endometrioid adenocarcinoma
arising in vaginal endometriosis: a case
report and literature review. G y n e c o l
Oncol 34: 232-236.
1156. Hastrup N, Sehested M (1985). Highgrade
mucoepidermoid carcinoma of the
breast. Histopathology 9: 887-892.
1157. Haswani P, Arseneau J, Ferenczy A
(1998). Primary signet cell carcinoma of the
uterine cervix: a clinicopathologic study of
two cases with review of the literature. Int
J Gynecol Cancer 8: 374-379.
1 1 5 8 . Hata JI, Ueyama Y, Tamaoki N,
Akatsuka A, Yoshimura S, Shimuzu K,
Morikawa Y, Furukawa T (1980). Human
yolk sac tumor serially transplanted in
nude mice: its morphologic and functional
properties. Cancer 46: 2446-2455.
1159. Hauptmann S, Dietel M (2001).
Serous tumors of low malignant potential
of the ovary-molecular pathology: part 2.
Virchows Arch 438: 539-551.
1160. Hausen H. (2000). Papillomaviruses
causing cancer: evasion from host-cell
control in early events in carcinogenesis.
J Natl Cancer Inst 92: 690-698.
1161. Hawkins RE, Schofield JB, Fisher C,
Wiltshaw E, McKinna JA (1992). The clinical
and histologic criteria that predict
metastases from cystosarcoma phyllodes.
Cancer 69: 141-147.
1162. Hayashi K, Bracken MB, Freeman DH
Jr., Hellenbrand K (1982). Hydatidiform
mole in the United States (1970-1977): a
statistical and theoretical analysis. Am J
Epidemiol 115: 67-77.
1163. Hayes MC, Scully RE (1987). Ovarian
steroid cell tumors (not otherwise specified).
A clinicopathological analysis of 63
cases. Am J Surg Pathol 11: 835-845.
1164. Hayes MC, Scully RE (1987). Stromal
luteoma of the ovary: a clinicopathological
analysis of 25 cases. Int J Gynecol Pathol
6: 313-321.
1165. Hayes MM, Seidman JD, Ashton MA
(1995). Glycogen-rich clear cell carcinoma
of the breast. A clinicopathologic study of
21 cases. Am J Surg Pathol 19: 904-911.
1166. Hays DM, Donaldson SS, Shimada H,
Crist WM, Newton WA Jr., Andrassy RJ,
Wiener E, Green J, Triche T, Maurer HM
(1997). Primary and metastatic rhabdomyosarcoma
in the breast: neoplasms of
adolescent females, a report from the
Intergroup Rhabdomyosarcoma Study.
Med Pediatr Oncol 29: 181-189.
1167. Healey CS, Dunning AM, Teare MD,
Chase D, Parker L, Burn J, Chang-Claude
J, Mannermaa A, Kataja V, Huntsman DG,
Pharoah PD, Luben RN, Easton DF, Ponder
BA (2000). A common variant in BRCA2 is
associated with both breast cancer risk
and prenatal viability. Nat Genet 26: 362-
364.
1168. Healey EA, Cook EF, Orav EJ, Schnitt
SJ, Connolly JL, Harris JR (1993).
Contralateral breast cancer: clinical characteristics
and impact on prognosis. J Clin
Oncol 11: 1545-1552.
1169. Heatley MK (2000). Adenomatous
hyperplasia of the rete ovarii.
Histopathology 36: 383-384.
1170. Heatley MK (2001). Polyp of the fallopian
tube. Pathology 33: 538-539.
1171. Hedenfalk I, Duggan D, Chen Y,
Radmacher M, Bittner M, Simon R, Meltzer
P, Gusterson B, Esteller M, Kallioniemi OP,
Wilfond B, Borg A, Trent J (2001). Geneexpression
profiles in hereditary breast
cancer. N Engl J Med 344: 539-548.
1172. Heffelfinger SC, Yassin R, Miller MA,
Lower EE (2000). Cyclin D1, retinoblastoma,
p53, and Her2/neu protein expression in
preinvasive breast pathologies: correlation
with vascularity. Pathobiology 68: 129-136.
1173. Hefler LA, Rosen AC, Graf AH,
Lahousen M, Klein M, Leodolter S,
Reinthaller A, Kainz C, Tempfer CB (2000).
The clinical value of serum concentrations
of cancer antigen 125 in patients with primary
fallopian tube carcinoma: a multicenter
study. Cancer 89: 1555-1560.
1 1 7 4 . Heifetz SA, Cushing B, Giller R,
Shuster JJ, Stolar CJ, Vinocur CD,
Hawkins EP (1998). Immature teratomas in
children: pathologic considerations: a
report from the combined Pediatric
Oncology Group/Children's Cancer Group.
Am J Surg Pathol 22: 1115-1124.
1175. Heim S, Teixeira MR, Dietrich CU,
Pandis N (1997). Cytogenetic polyclonality
in tumors of the breast. Cancer Genet
Cytogenet 95: 16-19.
1176. Heimann R, Lan F, McBride R,
Hellman S (2000). Separating favorable
from unfavorable prognostic markers in
breast cancer: the role of E-cadherin.
Cancer Res 60: 298-304.
1177. Heintz AP, Schaberg A, Engelsman E,
van Hall EV (1985). Placental-site trophoblastic
tumor: diagnosis, treatment,
and biological behavior. Int J Gynecol
Pathol 4: 75-82.
1178. Helland A, Karlsen F, Due EU, Holm R,
Kristensen G, Borresen-Dale A (1998).
Mutations in the TP53 gene and protein
expression of p53, MDM 2 and p21/WAF-1
in primary cervical carcinomas with no or
low human papillomavirus load. Br J
Cancer 78: 69-72.
1179. Heller DS, Keohane M, Bessim S,
Jagirdar J, Deligdisch L (1989). Pituitarycontaining
benign cystic teratoma arising
from the uterosacral ligament. Arch Pathol
Lab Med 113: 802-804.
1180. Heller DS, Rubinstein N, Dikman S,
Deligdisch L, Moss R (1991). Adenomatous
polyp of the fallopian tube. A case report.
J Reprod Med 36: 82-84.
1181. Hellman S, Harris JR (1987). The
appropriate breast cancer paradigm.
Cancer Res 47: 339-342.
1181 a. Hellstrom AC, Hue J, Silfversward
C, Auer G (1994). DNA-ploidy and mutant
p53 overexpression in primary fallopian
tube cancer. Int J Gynecol Cancer 4: 408-
413.
1182. Hellstrom AC, Tegerstedt G,
Silfversward C, Pettersson F (1999).
Malignant mixed mullerian tumors of the
ovary: histopathologic and clinical review
of 36 cases. Int J Gynecol Cancer 9: 312-
316.
1183. Helzlsouer KJ, Alberg AJ, Bush TL,
Longcope C, Gordon GB, Comstock GW
(1994). A prospective study of endogenous
hormones and breast cancer. C a n c e r
Detect Prev 18: 79-85.
1184. Hemminki K, Dong C, Vaittinen P
(1999). Familial risks in cervical cancer: is
there a hereditary component? Int J
Cancer 82: 775-781.
1185. Hemminki K, Vaittinen P (1999). Male
breast cancer: risk to daughters. Lancet
353: 1186-1187.
1186. Hendrickson M, Ross J, Eifel P,
Martinez A, Kempson R (1982). Uterine
papillary serous carcinoma: a highly malignant
form of endometrial adenocarcinoma.
Am J Surg Pathol 6: 93-108.
1187. Hendrickson MR, Kempson RL (1983).
Ciliated carcinoma--a variant of endometrial
adenocarcinoma: a report of 10 cases.
Int J Gynecol Pathol 2: 1-12.
1188. Hendrickson MR, Scheithauer BW
(1986). Primitive neuroectodermal tumor of
the endometrium: report of two cases, one
with electron microscopic observations.
Int J Gynecol Pathol 5: 249-259.
1189. Hennig Y, Caselitz J, Bartnitzke S,
Bullerdiek J (1997). A third case of a lowgrade
endometrial stromal sarcoma with a
t(7;17)(p14 approximately 21;q11.2 approxi -
mately 21). Cancer Genet Cytogenet 98: 84-
86.
1190. Henson DE, Ries L, Freedman LS,
Carriaga M (1991). Relationship among
outcome, stage of disease, and histologic
grade for 22,616 cases of breast cancer.
The basis for a prognostic index. Cancer
68: 2142-2149.
1191. Herbold DR, Axelrod JH, Bobowski
SJ, Freel JH (1988). Glassy cell carcinoma
of the fallopian tube. A case report. Int J
Gynecol Pathol 7: 384-390.
1192. Herbold DR, Fu YS, Silbert SW (1983).
Leiomyosarcoma of the broad ligament. A
case report and literature review with follow-up.
Am J Surg Pathol 7: 285-292.
1193. Herbst AL, Green TH Jr., Ulfelder H
(1970). Primary carcinoma of the vagina.
An analysis of 68 cases. Am J Obstet
Gynecol 106: 210-218.
1194. Herbst AL, Ulfelder H, Poskanzer DC
(1971). Adenocarcinoma of the vagina.
Association of maternal stilbestrol therapy
with tumor appearance in young women.
N Engl J Med 284: 878-881.
1195. Hermanek P, Hutter RV, Sobin LH,
Wittekind C (1999). International Union
Against Cancer. Classification of isolated
tumor cells and micrometastasis. Cancer
86: 2668-2673.
1 1 9 6 . Hernandez-Boussard TR-TPMRHP
(2001). IARC p53 mutation database: a relational
database to compile and analyze p53
mutations in human tumors and cell lines (R5
version). WHO/IARC http://www.iarc.fr/P53.
390 References